Valuation: Uscom Limited

Market Cap 3.12M 2.17M 1.95M 1.82M 1.65M 3.1M 207M 21.88M 8.54M 107M 8.16M 7.98M 345M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.08M 2.77M 2.58M 2.34M 4.39M 293M 30.97M 12.09M 152M 11.55M 11.3M 489M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.14
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 2011-03-06
Corporate Secretary 66 2016-05-23
Corporate Officer/Principal - 2018-05-27
Director TitleAgeSince
Chairman - 2009-10-31
Director/Board Member 66 2018-08-22
Director/Board Member 62 2019-12-15
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-.--%-76.00% 2.18M
+1.53%+1.68%+28.03%+37.80% 245B
+0.83%+2.84%+8.99%+6.77% 157B
-0.43%+1.38%-3.70%+53.28% 149B
-0.72%+3.42%-55.32%-14.17% 62.77B
+1.38%+0.78%+17.84%+21.30% 49.15B
+0.38%+5.25%-15.32%-15.68% 49.74B
+1.40%+2.90%+26.05%+56.05% 48.38B
-1.42%+5.26%+3.37%+40.29% 48.84B
+1.73%+0.14%+31.06%+71.11% 42.17B
Average +1.17%+1.75%+4.10%+18.07% 85.2B
Weighted average by Cap. +0.38%+1.50%+8.34%+29.73%

Financials

2024 2025
Net sales 3.73M 2.59M 2.33M 2.18M 1.97M 3.7M 247M 26.12M 10.2M 128M 9.74M 9.53M 412M 2.58M 1.8M 1.61M 1.51M 1.37M 2.56M 171M 18.08M 7.06M 88.66M 6.74M 6.59M 285M
Net income -2.07M -1.44M -1.3M -1.21M -1.1M -2.06M -137M -14.54M -5.68M -71.33M -5.42M -5.3M -229M -3.3M -2.3M -2.07M -1.93M -1.75M -3.28M -219M -23.15M -9.04M -114M -8.63M -8.44M -365M
Net Debt -1.53M -1.07M -958K -894K -810K -1.52M -101M -10.73M -4.19M -52.62M -4M -3.91M -169M 1.3M 903K 812K 758K 687K 1.29M 85.92M 9.09M 3.55M 44.59M 3.39M 3.32M 143M
Projected Income Statement - Annual - Uscom Limited
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35